These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15000258)
1. Inhibitory effect of FK506 and cyclosporine A on the growth and invasion of human liver cancer cells. Sakai M; Miyake H; Tashiro S; Okumura Y; Kido H J Med Invest; 2004 Feb; 51(1-2):63-9. PubMed ID: 15000258 [TBL] [Abstract][Full Text] [Related]
2. Different effects of cyclosporine a and FK506 on potassium transport systems in MDCK cells. Aker S; Heering P; Kinne-Saffran E; Deppe C; Grabensee B; Kinne RK Exp Nephrol; 2001; 9(5):332-40. PubMed ID: 11549851 [TBL] [Abstract][Full Text] [Related]
3. The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion. Kawahara T; Kashiwagi E; Ide H; Li Y; Zheng Y; Ishiguro H; Miyamoto H Prostate; 2015 May; 75(6):573-84. PubMed ID: 25631176 [TBL] [Abstract][Full Text] [Related]
4. Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro. Batten P; McCormack AM; Page CS; Yacoub MH; Rose ML Transplantation; 1999 Nov; 68(10):1552-60. PubMed ID: 10589954 [TBL] [Abstract][Full Text] [Related]
5. [Effects of tacrolimus and cyclosporine on albumin secretion in cultured human hepatocyte]. Li Y; Liu ZH; Huang YF; Li LS; Liu FY; Peng YM Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):387-91. PubMed ID: 16859130 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling. Hafizi S; Mordi VN; Andersson KM; Chester AH; Yacoub MH Vascul Pharmacol; 2004; 41(4-5):167-76. PubMed ID: 15607500 [TBL] [Abstract][Full Text] [Related]
7. Effect of tacrolimus and cyclosporine A on suppression of albumin secretion induced by inflammatory cytokines in cultured human hepatocytes. Li Y; Liu FY; Liu ZH; Huang YF; Li LS; Zhang X; Peng YM Inflamm Res; 2006 May; 55(5):216-20. PubMed ID: 16830109 [TBL] [Abstract][Full Text] [Related]
8. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells. Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971 [TBL] [Abstract][Full Text] [Related]
9. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Andersson J; Nagy S; Groth CG; Andersson U Immunology; 1992 Jan; 75(1):136-42. PubMed ID: 1371491 [TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A, but not FK506, increases arachidonic acid release and inhibits proliferation of pituitary corticotrope tumor cells. Pompeo A; Baldassare M; Luini A; Buccione R Life Sci; 1999; 64(10):837-46. PubMed ID: 10096434 [TBL] [Abstract][Full Text] [Related]
11. Effects of FK506 and cyclosporin A on proliferation, histamine release and phenotype of murine mast cells. Toyota N; Hashimoto Y; Matsuo S; Kitamura Y; Iizuka H Arch Dermatol Res; 1996 Jul; 288(8):474-80. PubMed ID: 8844128 [TBL] [Abstract][Full Text] [Related]
12. [Effects of ciclosporin and tacrolimus on replication of hepatitis B virus in vitro: a comparative study]. Xia WL; Xie HY; Shen Y; Wu LM; Zhang F; Zheng SS Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):111-5. PubMed ID: 16620716 [TBL] [Abstract][Full Text] [Related]
13. Rapamycin and FK506 differentially inhibit mast cell cytokine production and cytokine-induced proliferation and act as reciprocal antagonists. Hatfield SM; Mynderse JS; Roehm NW J Pharmacol Exp Ther; 1992 Jun; 261(3):970-6. PubMed ID: 1376361 [TBL] [Abstract][Full Text] [Related]
14. Lesser reduction in bone mineral density by the immunosuppressant, FK506, compared with cyclosporine in rats. Inoue T; Kawamura I; Matsuo M; Aketa M; Mabuchi M; Seki J; Goto T Transplantation; 2000 Sep; 70(5):774-9. PubMed ID: 11003356 [TBL] [Abstract][Full Text] [Related]
15. Triptolide is a potent suppressant of C3, CD40 and B7h expression in activated human proximal tubular epithelial cells. Hong Y; Zhou W; Li K; Sacks SH Kidney Int; 2002 Oct; 62(4):1291-300. PubMed ID: 12234299 [TBL] [Abstract][Full Text] [Related]
16. Effect of cyclosporin and tacrolimus (FK506) on the antigen-induced mediator release, membrane potential and 86Rb+/K+ and Ca2+ fluxes in the RBL-2H3 cell line. Narenjkar J; Assem el-SK; Wan BY; Marsh S; Ezeamuzie CI Int Immunopharmacol; 2006 May; 6(5):742-9. PubMed ID: 16546704 [TBL] [Abstract][Full Text] [Related]
17. Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures. Igarashi K; Hirotani H; Woo JT; Stern PH Bone; 2004 Jul; 35(1):47-56. PubMed ID: 15207740 [TBL] [Abstract][Full Text] [Related]
18. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma. Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342 [TBL] [Abstract][Full Text] [Related]
19. The effects of cyclosporin A and FK506 on proliferation and IL-8 production of cultured human keratinocytes. Kaplan A; Matsue H; Shibaki A; Kawashima T; Kobayashi H; Ohkawara A J Dermatol Sci; 1995 Sep; 10(2):130-8. PubMed ID: 8534611 [TBL] [Abstract][Full Text] [Related]
20. Effects of FK506, 15-deoxyspergualin, and cyclosporine on experimental autoimmune uveoretinitis in the rat. Mochizuki M; Kawashima H Autoimmunity; 1990; 8(1):37-41. PubMed ID: 1717007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]